2022.11.30 - News
New Investment in Yuimedi, Inc.
We, DG Daiwa Ventures Inc. subscribed for a third party allocation of new shares in Yuimedi.
Yuimedi is a potential global healthcare data player who can enhance the efficiency of developing new treatments/medicines by offering data-cleansing solutions dedicated to healthcare data and insights on data usage.
In the bigger picture, DGDV considers what Yuimedi offers would even tackle the global challenge, medical cost cuts. Yuimedi’s strategy of becoming a healthcare data platformer based on data-cleansing is unique worldwide, and we believe Yuimedi can become an innovator in healthcare data utilization.
For details, please refer to the press releases of Yuimedi, Inc.